Literature DB >> 11642687

Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease.

D Frosch1, F Porzsolt, R Heicappell, K Kleinschmidt, M Schatz, S Weinknecht, R M Kaplan.   

Abstract

BACKGROUND: The quality of well-being scale (QWB) and the Medical Outcome Study 36-item short form (SF-36) are alternative methods for measuring general health outcomes. Few studies compare these approaches against one another and no studies have compared German language versions.
METHOD: A German language version of the self-administered quality of well-being scale (QWB-SA) was developed using forward and back translation methods. The German QWB-SA and a German language version of the SF-36 were administered to clinical population groups with current diagnoses of prostate cancer, benign hyperplasia of the prostate, colon cancer, and rectal cancer. Data were obtained from four German clinics. In addition to the quality of life measures, data on cancer stage and disease state were obtained.
RESULTS: The QWB-SA and SF-36 were highly correlated. The QWB-SA was systematically related to disease state. Those with no symptomatic evidence had the highest scores followed by those who were stable with no metastatic disease and those with metastatic progression. Similar patterns were found for most SF-36 scales although the SF-36 failed to discriminate between those with no evidence of disease and those with stable disease without metastasis.
CONCLUSIONS: Both the QWB-SA and SF-36 perform as expected using German language translations. Although both measures differentiate patients with metastasis from those without symptoms, the QWB-SA better differentiated those with no evidence of disease from those with stable disease without metastasis.

Entities:  

Mesh:

Year:  2001        PMID: 11642687     DOI: 10.1023/a:1016771205405

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  16 in total

1.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

2.  Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  S D Keller; J E Ware; B Gandek; N K Aaronson; J Alonso; G Apolone; J B Bjorner; J Brazier; M Bullinger; S Fukuhara; S Kaasa; A Leplège; R W Sanson-Fisher; M Sullivan; S Wood-Dauphinee
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 3.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

4.  Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.

Authors:  C Bombardier; J Ware; I J Russell; M Larson; A Chalmers; J L Read
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

5.  Value judgment in the Oregon Medicaid experiment.

Authors:  R M Kaplan
Journal:  Med Care       Date:  1994-10       Impact factor: 2.983

6.  Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights.

Authors:  D J Balaban; P C Sagi; N I Goldfarb; S Nettler
Journal:  Med Care       Date:  1986-11       Impact factor: 2.983

7.  The Quality of Well-Being Scale: critical similarities and differences with SF-36.

Authors:  R M Kaplan; T G Ganiats; W J Sieber; J P Anderson
Journal:  Int J Qual Health Care       Date:  1998-12       Impact factor: 2.038

8.  German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment.

Authors:  M Bullinger
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

9.  Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R M Kaplan; J P Anderson; T L Patterson; J A McCutchan; J D Weinrich; R K Heaton; J H Atkinson; L Thal; J Chandler; I Grant
Journal:  Psychosom Med       Date:  1995 Mar-Apr       Impact factor: 4.312

10.  Application of a general health policy model in the American health care crisis.

Authors:  R M Kaplan
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

View more
  6 in total

1.  Health-related quality of life in older adults at risk for disability.

Authors:  Erik J Groessl; Robert M Kaplan; W Jack Rejeski; Jeffrey A Katula; Abby C King; Georita Frierson; Nancy W Glynn; Fang-Chi Hsu; Michael Walkup; Marco Pahor
Journal:  Am J Prev Med       Date:  2007-09       Impact factor: 5.043

2.  Physical Activity and Performance Impact Long-term Quality of Life in Older Adults at Risk for Major Mobility Disability.

Authors:  Erik J Groessl; Robert M Kaplan; W Jack Rejeski; Jeffrey A Katula; Nancy W Glynn; Abby C King; Stephen D Anton; Michael Walkup; Ching-Ju Lu; Kieran Reid; Bonnie Spring; Marco Pahor
Journal:  Am J Prev Med       Date:  2019-01       Impact factor: 5.043

3.  Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.

Authors:  Murray Krahn; Karen E Bremner; George Tomlinson; Paul Ritvo; Jane Irvine; Gary Naglie
Journal:  Qual Life Res       Date:  2006-11-08       Impact factor: 4.147

4.  Preference-weighted health-related quality of life measures and substance use disorder severity.

Authors:  Jeffrey M Pyne; Michael French; Kathryn McCollister; Shanti Tripathi; Richard Rapp; Brenda Booth
Journal:  Addiction       Date:  2008-04-07       Impact factor: 6.526

5.  The effect of CPAP on HRQOL as measured by the Quality of Well-Being Self Administered Questionaire (QWB-SA).

Authors:  Salma Batool-Anwar; Olabimpe Omobomi; Stuart F Quan
Journal:  Southwest J Pulm Crit Care       Date:  2020

6.  Quality of life of men treated with brachytherapies for prostate cancer.

Authors:  Elise L Lev; Lucille Sanzero Eller; Glen Gejerman; Patricia Lane; Steven V Owen; Michele White; Njoki Nganga
Journal:  Health Qual Life Outcomes       Date:  2004-06-15       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.